Probiotics for Gallstones in Post-bariatric Surgery Patients
Launched by SHANDONG LINGLONG YINGCHENG HOSPITAL · Feb 29, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether probiotics can help prevent gallstones from forming in patients who have undergone bariatric surgery, a procedure designed to help people lose weight. Gallstones can be a common issue after this type of surgery, partly due to the rapid weight loss and changes in the body. The researchers want to find out if taking probiotics, which are good bacteria that can help with digestion, can not only reduce the risk of gallstones but also improve the overall quality of life for these patients.
To participate in this trial, you need to be between 20 and 60 years old, undergoing bariatric surgery for obesity, and willing to attend regular follow-up appointments after the surgery. However, if you already have gallstones or are not comfortable taking probiotics, you would not be eligible. Participants can expect to take probiotics and monitor their health and symptoms over time, helping researchers understand how these supplements might benefit those recovering from bariatric surgery. This study is currently recruiting participants, and your involvement could help improve treatment options for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients receiving bariatric surgery for morbid obesity
- • Patiets at ages between 20 to 60 y/o
- • Patients willing to follow up regulary after bariatric surgery
- Exclusion Criteria:
- • Patients having gallstones before bariatric surgery
- • Patients refusing taking probiotics or refusing regular follow up after bariatric surgery
About Shandong Linglong Yingcheng Hospital
Shandong Linglong Yingcheng Hospital is a leading healthcare institution committed to advancing medical research and patient care through innovative clinical trials. Recognized for its state-of-the-art facilities and a multidisciplinary team of experienced professionals, the hospital focuses on a wide range of therapeutic areas, aiming to enhance treatment outcomes and improve quality of life for patients. With a dedication to ethical standards and regulatory compliance, Shandong Linglong Yingcheng Hospital actively collaborates with researchers and industry partners to contribute to the development of new therapies and medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Yantai, Shandong, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported